Section | Title | Authors | Address |
---|
|
Genes | ABL1 (v-abl Abelson murine leukemia viral oncogene homolog 1) | Turhan AG | http://atlasgeneticsoncology.org/Genes/ABLID1.html |
Genes | ALDH2 (aldehyde dehydrogenase 2 family (mitochondrial)) | Vasiliou V, Sophos N | http://atlasgeneticsoncology.org/Genes/ALDH2ID250.html |
Genes | ALK (anaplastic lymphoma receptor tyrosine kinase) | Huret JL | http://atlasgeneticsoncology.org/Genes/ALKID16.html |
Genes | ASPSCR1 (Alveolar soft part sarcoma critical region 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/ASPSCR1ID358.html |
Genes | ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | Huret JL | http://atlasgeneticsoncology.org/Genes/ATICID227.html |
Genes | BCR (Breakpoint cluster region) | Turhan AG | http://atlasgeneticsoncology.org/Genes/BCRID55.html |
Genes | BIRC3 (baculoviral IAP repeat-containing 3) | Baens M, Marynen P | http://atlasgeneticsoncology.org/Genes/BIRC3ID239.html |
Genes | CCDC6 (coiled-coil domain containing 6) | Cross NCP | http://atlasgeneticsoncology.org/Genes/H4ID280.html |
Genes | CDKN1A (cyclin-dependent kinase inhibitor 1A) | Javelaud D, Besanc F | http://atlasgeneticsoncology.org/Genes/CDKN1AID139.html |
Genes | CLTC (clathrin heavy polypeptide) | Huret JL | http://atlasgeneticsoncology.org/Genes/CLTCID360.html |
Genes | CLTCL1 (clathrin heavy polypeptide-like 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/CLTCL1ID361.html |
Genes | COL1A1 (collagen, type I, alpha 1) | Simon MP, Maire G, Pedeutour F | http://atlasgeneticsoncology.org/Genes/COL1A1ID186.html |
Genes | DDB2 (xeroderma pigmentosum, complementation group E) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPEID298.html |
Genes | ERCC2 (Excision repair cross-complementing rodent repair deficiency, complementation group 2) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPDID297.html |
Genes | ERCC3 (Excision repair cross-complementing rodent repair deficiency, complementation group 3) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPBID296.html |
Genes | ERCC4 (xeroderma pigmentosum, complementation group F) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPFID299.html |
Genes | ERCC5 (xeroderma pigmentosum, complementation group G) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPGID300.html |
Genes | ERCC6 (excision repair cross-complementing rodent repair deficiency, complementation group 6) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/CSBID302.html |
Genes | ERCC8 (excision repair cross-complementing rodent repair deficiency, complementation group 8) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/CSAID301.html |
Genes | FANCA (Fanconi anemia, complementation group A) | Joenje H | http://atlasgeneticsoncology.org/Genes/FA1ID102.html |
Genes | FGFR1OP (FGFR1 oncogene partner) | Pébusque MJ | http://atlasgeneticsoncology.org/Genes/FOPID140.html |
Genes | FNBP1 (Formin Binding Protein 17) | Fuchs U, Borkhardt A | http://atlasgeneticsoncology.org/Genes/FBP17ID353.html |
Genes | FOXO4 (myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7) | Bojesen SE | http://atlasgeneticsoncology.org/Genes/AFX1ID57.html |
Genes | GHRL (ghrelin/obestatin prepropeptide) | Tomasetto C | http://atlasgeneticsoncology.org/Genes/GhrelinID327.html |
Genes | MAD2L1 (mitotic arrest deficient 2, yeast, human homolog like-1) | Petty EM, Myrie K | http://atlasgeneticsoncology.org/Genes/MAD2L1ID304.html |
Genes | MALT1 (mucosa associated lymphoid tissue lymphoma translocation gene 1) | Baens M, Marynen P | http://atlasgeneticsoncology.org/Genes/MALT1ID240.html |
Genes | MET met proto-oncogene (hepatocyte growth factor receptor) | Angeloni D, Nickerson ML, Schmidt L | http://atlasgeneticsoncology.org/Genes/METID131.html |
Genes | MRTFA (myocardin related transcription factor A) | Huret JL | http://atlasgeneticsoncology.org/Genes/MALID352.html |
Genes | MSN (moesin) | Huret JL | http://atlasgeneticsoncology.org/Genes/MSNID363.html |
Genes | MST1R (Macrophage stimulating 1 receptor) | Angeloni D, Lerman MI | http://atlasgeneticsoncology.org/Genes/RONID287.html |
Genes | NF2 (neurofibromatosis type 2) | Gusella JF | http://atlasgeneticsoncology.org/Genes/NF2ID117.html |
Genes | NPM1 (nucleophosmin) | Huret JL | http://atlasgeneticsoncology.org/Genes/NPM1ID22.html |
Genes | NQO1 (NAD (P)H dehydrogenase, quinone 1) | Ross D | http://atlasgeneticsoncology.org/Genes/NQO1ID375.html |
Genes | PDGFB platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | Simon MP, Maire G, Pedeutour F | http://atlasgeneticsoncology.org/Genes/PDGFBID155.html |
Genes | POLH (polymerase (DNA direct), eta) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPVID303.html |
Genes | RAP1A (RAP11, member of RAS oncogene family) | Gunzburg J de | http://atlasgeneticsoncology.org/Genes/RAP1AID272.html |
Genes | RAP1B (RAP1B, member of RAS oncogene family) | Gunzburg J de | http://atlasgeneticsoncology.org/Genes/RAP1BID273.html |
Genes | RAP2A (RAP2A, member of RAS oncogene family) | Gunzburg J de | http://atlasgeneticsoncology.org/Genes/RAP2AID274.html |
Genes | RAP2B (RAP2B, member of RAS oncogene family) | Gunzburg J de | http://atlasgeneticsoncology.org/Genes/RAP2BID275.html |
Genes | RASSF1 (Ras association (RalGDS/AF-6) domain family member) | Angeloni D, Lerman MI | http://atlasgeneticsoncology.org/Genes/RASSF1ID377.html |
Genes | RBM15 (RNA binding motif protein 15) | Huret JL | http://atlasgeneticsoncology.org/Genes/OTTID175.html |
Genes | RECQL4 (RecQ protein-like 4 | Beghini A | http://atlasgeneticsoncology.org/Genes/RECQL4ID285.html |
Genes | SEPT9 (MLL septin-like fusion) | Kalikin LM, Petty EM | http://atlasgeneticsoncology.org/Genes/MSFID208.html |
Genes | TFE3 (transcription factor E3) | Huret JL | http://atlasgeneticsoncology.org/Genes/TFE3ID86.html |
Genes | TFF3 trefoil factor 3 (intestinal) | Tomasetto C | http://atlasgeneticsoncology.org/Genes/TFF3ID265.html |
Genes | TP53 (Tumour protein p53 (Li-Fraumeni syndrome)) | Soussi T | http://atlasgeneticsoncology.org/Genes/P53ID88.html |
Genes | TPM3 (tropomyosin 3) | Huret JL | http://atlasgeneticsoncology.org/Genes/TPM3ID225.html |
Genes | TPM4 (tropomyosin) | Huret JL | http://atlasgeneticsoncology.org/Genes/TPM4ID359.html |
Genes | TSC1 (Tuberous Sclerosis 1) | van Slegtenhorst M, Petri Henske E | http://atlasgeneticsoncology.org/Genes/TSC1ID183.html |
Genes | TSC2 (tuberous sclerosis 2) | Astrinidis A, Petri Henske E | http://atlasgeneticsoncology.org/Genes/TSC2ID184.html |
Genes | WRN (Werner syndrome, RecQ helicase-like) | Amor-Guéret M | http://atlasgeneticsoncology.org/Genes/WRNID284.html |
Genes | XPA xeroderma pigmentosum, complementation group A) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPAID104.html |
Genes | XPC (xeroderma pigmentosum, complementation group C) | Stary A, Sarasin A | http://atlasgeneticsoncology.org/Genes/XPCID122.html |
Genes | ZMYM2 (fused in myeloproliferative disorders). | Pébusque MJ | http://atlasgeneticsoncology.org/Genes/ZNF198ID114.html |
Leukemias | 11q23 rearrangements (KMT2A) in leukaemia | Huret JL | http://atlasgeneticsoncology.org/Anomalies/11q23ID1030.html |
Leukemias | Anaplastic large cell lymphoma (ALCL) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/AnaplLargeCelLymphID2103.html |
Leukemias | Atypical Chronic Myeloid Leukemia (aCML) | Hernandez JM, Gutierrez NC, Garcia JL | http://atlasgeneticsoncology.org/Anomalies/aCMLID2117.html |
Leukemias | Biphenotypic Acute Leukaemia (BAL) | Killick SB, Matutes E | http://atlasgeneticsoncology.org/Anomalies/BiphenoALID1214.html |
Leukemias | Burkitt's lymphoma (BL) | Cuneo A, Castoldi GL | http://atlasgeneticsoncology.org/Anomalies/BurkittID2077.html |
Leukemias | Chronic Myelomonocytic Leukemia (CMML) | Hess JL | http://atlasgeneticsoncology.org/Anomalies/CMMLID1098.html |
Leukemias | Classification of T-Cell disorders | Brito-Babapulle V, Matutes E, Catovsky D | http://atlasgeneticsoncology.org/Anomalies/TcellClassifID2079.html |
Leukemias | Follicular lymphoma (FL) | Cuneo A, Castoldi GL | http://atlasgeneticsoncology.org/Anomalies/FollLymphomID2075.html |
Leukemias | Marginal Zone B-cell lymphoma | Cuneo A, Castoldi GL | http://atlasgeneticsoncology.org/Anomalies/MarginalZoneBID2078.html |
Leukemias | del(11q) in non-Hodgkin's lymphoma (NHL) | Cuneo A, Castoldi GL | http://atlasgeneticsoncology.org/Anomalies/del11qNHLID2020.html |
Leukemias | del(13q) in multiple myeloma | Viguié F | http://atlasgeneticsoncology.org/Anomalies/del13qMMyeloID2094.html |
Leukemias | del(13q) in myeloid malignancies | Boyer J | http://atlasgeneticsoncology.org/Anomalies/del13qID1096.html |
Leukemias | del(7q) in non-Hodgkin's lymphoma (NHL) | Cuneo A, Castoldi GL | http://atlasgeneticsoncology.org/Anomalies/del7qNHLID2082.html |
Leukemias | inv(2)(p23q35) ATIC/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv2p23q35ID1172.html |
Leukemias | t(11;18)(q21;q21) BIRC3/MALT1 | Baens M, Marynen P | http://atlasgeneticsoncology.org/Anomalies/t1118ID2022.html |
Leukemias | t(1;2)(p22;p12) IGK/BCL10 | Cuneo A, Castoldi GL | http://atlasgeneticsoncology.org/Anomalies/t114ID2044.html |
Leukemias | t(1;2)(q25;p23) TPM3/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0102ID1168.html |
Leukemias | t(2;19)(p12;q13.3) IGK/BCL3 | Meeus P, Michaux L | http://atlasgeneticsoncology.org/Anomalies/t1419ID2050.html |
Leukemias | t(2;22)(p23;q11) CLTCL1/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0222ID1220.html |
Leukemias | t(2;3)(p23;q21) TFG/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0203ID1217.html |
Leukemias | t(2;5)(p23;q35) NPM1/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0205ID2000.html |
Leukemias | t(3;11)(q28;q23) KMT2A/LPP | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0311q28q23ID1223.html |
Leukemias | t(5;10)(q33;q21) CCDC6/PDGFRB | Mecucci C | http://atlasgeneticsoncology.org/Anomalies/t510ID1166.html |
Leukemias | t(5;11)(q31;q23) KMT2A/ARHGAP26 | Bojesen SE | http://atlasgeneticsoncology.org/Anomalies/t0511ID1192.html |
Leukemias | t(7;12)(q36;p13) MNX1/ETV6 | Tosi S | http://atlasgeneticsoncology.org/Anomalies/t0712ID1177.html |
Leukemias | t(7;14)(q35;q32.1) TRB/TCL1A | Boyer J | http://atlasgeneticsoncology.org/Anomalies/inv14ID2049.html |
Leukemias | t(8;14)(q24;q11) TRA/MYC | Boyer J | http://atlasgeneticsoncology.org/Anomalies/t0814ID1061.html |
Leukemias | t(9;11)(q34;q23) FNBP1/KMT2A | Fuchs U, Borkhardt A | http://atlasgeneticsoncology.org/Anomalies/t0911FBPID1205.html |
Leukemias | t(X;11)(q13;q23) KMT2A/FOXO4 | Bojesen SE | http://atlasgeneticsoncology.org/Anomalies/t0X11ID1127.html |
Leukemias | t(X;2)(q11;p23) MSN/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Bone: Fibrous dysplasia of the bone | Dal Cin P | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Kidney: Chromophobe renal cell carcinoma | Dal Cin P | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Kidney: Renal cell carcinoma with t(X;17)(p11;q25) ASPSCR1/TFE3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Liver: Hepatoblastoma | Steenman M | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Liver: Hepatocellular carcinoma | Debuire B, Lemoine A | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Nervous system: Embryonal tumors: Neuroblastoma | Kaneko Y | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Nervous system: Ependymomas | Capodano AM | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Nervous system: Peripheral nerve sheath tumors | Mertens F, Lothe RA | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Skin: Cutaneous benign fibrous histiocytomas | Vanni R | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Soft Tissues: Alveolar soft part sarcoma with t(X;17)(p11;q25) ASPSCR1/TFE3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Soft Tissues: Inflammatory myofibroblastic tumor | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Soft Tissues: Inflammatory myofibroblastic tumor with t(1;2)(q21;p23) TPM3/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Soft Tissues: Inflammatory myofibroblastic tumor with t(2;17)(p23;q23) CLTC/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Soft Tissues: Inflammatory myofibroblastic tumor with t(2;19)(p23;p13) TPM4/ALK | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Squamous cell cancer | Van Dyke DL | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Solid Tumors | Testis: Germ cell tumors | Looijenga LHJ | http://atlasgeneticsoncology.org/Anomalies/t0X02ID1216.html |
Cancer-Prones | Bruton's agammaglobulinemia | Atkin NB | http://atlasgeneticsoncology.org/Kprones/BrutonAgammaID10023.html |
Cancer-Prones | Dyskeratosis congenita (DKC) | Viguié C | http://atlasgeneticsoncology.org/Kprones/DyskeratosID10034.html |
Cancer-Prones | Familial monosomy 7 syndrome | Hess JL | http://atlasgeneticsoncology.org/Kprones/FamilMono7ID10059.html |
Cancer-Prones | Familial nervous system tumour syndromes | Capodano AM | http://atlasgeneticsoncology.org/Kprones/FamilNervousCanID10067.html |
Cancer-Prones | Lhermitte-Duclos disease | Longy M | http://atlasgeneticsoncology.org/Kprones/LhermitteDuclID10065.html |
Cancer-Prones | Lynch Syndrome | Laurent-Puig P | http://atlasgeneticsoncology.org/Kprones/HNPCCLynchID10049.html |
Cancer-Prones | Multiple endocrine neoplasia type 2 (MEN2) | Giraud S | http://atlasgeneticsoncology.org/Kprones/MEN2ID10009.html |
Cancer-Prones | Neurofibromatosis type 2 (NF2) | Gusella JF | http://atlasgeneticsoncology.org/Kprones/NF2KprID10007.html |
Cancer-Prones | Rothmund-Thomson syndrome (RTS) | Beghini A, Larizza L | http://atlasgeneticsoncology.org/Kprones/RothmundID10021.html |
Cancer-Prones | Rubinstein-Taybi syndrome (RTS) | Lacombe B | http://atlasgeneticsoncology.org/Kprones/RubinsTaybiID10063.html |
Cancer-Prones | Von Hippel-Lindau | Richard S | http://atlasgeneticsoncology.org/Kprones/VHLKprID10010.html |
Deep Insights | Chromosomal Instability in Cancer: Causes and Consequences | Gisselsson D | http://atlasgeneticsoncology.org/Deep/ChromosomInstabilID20023.html |
Deep Insights | Classification of B-cell non-Hodgkin's lymphomas (NHL) : cytogenetic entities, immunopheneotype and clinical features | Gisselsson D | http://atlasgeneticsoncology.org/Deep/BNHLclassifID20012.html |
Deep Insights | Classification of T-cell disorders | Brito-Babapulle V, Matutes E, Catovsky D | http://atlasgeneticsoncology.org/Deep/TcellClassifID20022.html |
Deep Insights | Deregulation of genetic pathways in neuroendocrine tumors | Calender A | http://atlasgeneticsoncology.org/Deep/GenetNeuroendocID20039.html |
Deep Insights | Nucleotide excision repair | Mullenders LHF, Stary A, Sarasin A | http://atlasgeneticsoncology.org/Deep/ExcisRepairID20014.html |
Deep Insights | Ring chromosomes: vicious circles at the end and beginning of life | Gisselsson D | http://atlasgeneticsoncology.org/Deep/RingChromosID20030.html |
Deep Insights | Tying up Loose Ends: Generation and Repair of DNA Double-Strand Breaks | Smith J, Smith K, Mézard C | http://atlasgeneticsoncology.org/Deep/DoubleStrandBreaksID20008.html |
Deep Insights | Upstream Signal Transduction of NF-kB Activation | Chen F, Bower J, Demers LM, Shi X | http://atlasgeneticsoncology.org/Deep/NFKBID20033.html |
Educational Items | Cystic Fibrosis and CFTR Gene | Fanen P, Hasnain A | http://atlasgeneticsoncology.org/Educ/CistFibID30032EL.html |
Educational Items | Cystic Fibrosis and CFTR Gene | Fanen P, Hasnain A | http://atlasgeneticsoncology.org/Educ/CistFibID30032ES.html |
Educational Items | Gènes du Développement. Exemple: Développement du Squelette chez l' Humain | Bonaventure J | http://atlasgeneticsoncology.org/Educ/GenDevelLongFr.html |
Educational Items | Gènes du Développement. Exemple: Développement du squelette chez l'humain | Bonaventure J | http://atlasgeneticsoncology.org/Educ/GenDevelShortFr.html |
Educational Items | Hardy-Weinberg model | Kalmes R, Huret JL | http://atlasgeneticsoncology.org/Educ/HardyEng.html |
Educational Items | La fibrosis quística y el gen CFTR | Fanen P, Hasnain A | http://atlasgeneticsoncology.org/Educ/CistFibID30032SS.html |
Educational Items | Modèle de Hardy-Weinberg | Kalmes R, Huret JL | http://atlasgeneticsoncology.org/Educ/Hardy.html |
Educational Items | Modelo de Hardy-Weinberg | Kalmes R, Huret JL | http://atlasgeneticsoncology.org/Educ/HardySp.html |
Educational Items | Mucoviscidose et Gène CFTR | Fanen P, Hasnain A | http://atlasgeneticsoncology.org/Educ/CisticFibFr.html |
Educational Items | Mucoviscidose et Gène CFTR | Fanen P, Hasnain A | http://atlasgeneticsoncology.org/Educ/CisticFibFr2.html |
Educational Items | Skeletal Development in Human | Bonaventure J | http://atlasgeneticsoncology.org/Educ/GenDevelLongEngl.html |
Educational Items | Skeletal Development in Human | Bonaventure J | http://atlasgeneticsoncology.org/Educ/GenDevelShortEngl.html |
Educational Items | Skelettentwicklung beim Menschen | Bonaventure J | http://atlasgeneticsoncology.org/Educ/GenDevelShortGermID30015DS.html |